Narcolepsy is a long-term neurological disorder that involves a decreased ability to regulate sleep-wake cycles. Symptoms include periods of excessive daytime sleepiness that usually last from seconds to minutes and may occur at any time. About 70% of people also experience episodes of sudden loss of muscle strength, known as cataplexy. These spells can be brought on by strong emotions. Less commonly, there may be inability to move or vivid hallucinations while falling asleep or waking up. People with narcolepsy tend to sleep about the same number of hours per day as people without, but the quality of sleep tends to be worse.
Scope of the Report:
This report focuses on the Narcolepsy Drug in North America market, especially in United States, Canada and Mexico. This report categorizes the market based on manufacturers, countries, type and application.
To Browse Complete report visit @ https://www.reportsmonitor.com/north-america-narcolepsy-drug-market-by-manufacturers-countries-type-and-application-forecast-to-2022/
Market Segment by Manufacturers, this report covers
Market Segment by Countries, covering
Market Segment by Type, covers
Market Segment by Applications, can be divided into
Daytime Extreme Sleepiness
To Get Request Sample report visit @ https://www.reportsmonitor.com/request-sample/?post=219384
Reports Monitor (ReportsMonitor.com) is a platform for companies looking to meet their market research and business intelligence requirements. Our aim is to change the dynamics of the Market Research industry by providing quality intelligence backed by data. Your requirement for market forecasting is fulfilled by our exclusive quantitative and analytics driven intelligence. We have a vast collection of reports, covering maximum industries worldwide. Our process is meticulously planned and executed in order to use maximum resources and explore the market for getting genuine insights. The prime focus is to get reliable data, Decision makers can now rely on our distinct data gathering methods to get factual market forecasting and detailed analysis.
Direct: +1 513 549-5911
Email: [email protected]